FTC Sues Endo, Generics For Pay-For-Delay Agreements
The Federal Trade Commission has sued Endo and other pharmaceutical companies in Pennsylvania federal court for allegedly delaying generic competition for the drugs Opana ER and Lidoderm, marking the first time...To view the full article, register now.
Already a subscriber? Click here to view full article